Brought to you by:
‘Female sex predicts reintervention after elective EVAR for AAA’
Females were found to be at greater risk of reintervention following elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) at both the one- and five-year mark following their initial procedure, researchers in New Jersey discovered. The retrospective chart…
VEITH 2021: Researchers present ex vivo demonstration of fluoroscopy-free complex AAA stent placement
“I think this represents the beginning of the end of an era where we have to use lead to perform these procedures.” Those were the words delivered by Gustavo Oderich, MD, professor and chief of vascular and endovascular surgery at…
WVS 2021: Community surgeons report improved rAAA survival after adoption of EVAR-first approach
Overall survival improved from 71% to 80% after a group of community practice surgeons started using an endovascular-first approach to ruptured abdominal aortic aneurysm (rAAA) repair. Scott S. Berman, MD, a vascular surgeon at Pima Heart & Vascular in Tucson,…
Endologix launches randomized study of Alto EVAR device
Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s Alto abdominal stent graft system to other commercially available endovascular aneurysm repair (EVAR) devices for the treatment of abdominal…
First patient enrolled in AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicenter early feasibility study of the Impede-FX RapidFill device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The Dutch study’s first procedure…
Final Meet the Experts session is July 15
Practicing vascular surgeons, learn all about preventing and managing type II endoleaks—a common situation faced by specialists—from the experts on Thursday, July 15. Benjamin Jackson, MD, will moderate the session, alongside panelists Wei Zhou, MD, and Sunita Srivastava, MD. Participation…
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs) and the first-ever Corner Stitch column were among the best-read stories here on the Vascular Specialist…
The top 10 most popular stories from April
Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels) at vascular surgery meetings, and some of the latest details on the 2021 Vascular Annual Meeting…
Endologix announces launch of Alto abdominal stent graft in Canada
Endologix today announced the first implant of its Alto abdominal stent graft in Canada following recent approval from Health Canada. Alto was also recently approved for commercial sale in Argentina. The company heralds the Alto abdominal stent graft system as…
Hitting the spot: EVAR for rAAA should be ‘treatment of choice’ in 2021
If the equipment and requisite skillset are available, and a patient’s anatomy is suitable, endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysms (rAAAs) “should be the treatment of choice in 2021 and beyond,” vascular titan Frank Veith, MD, argued…